210 related articles for article (PubMed ID: 3162752)
1. Immunophenotype of clonogenic cells in myeloid leukaemia.
Kabral A; Bradstock KF; Grimsley P; Favaloro EJ
Leuk Res; 1988; 12(1):51-9. PubMed ID: 3162752
[TBL] [Abstract][Full Text] [Related]
2. Immunophenotype of blast cells in acute myeloid leukemia may be a useful predictive factor for outcome.
Tucker J; Dorey E; Gregory WM; Simpson AP; Amess JA; Lister TA; Horton MA
Hematol Oncol; 1990; 8(1):47-58. PubMed ID: 2404842
[TBL] [Abstract][Full Text] [Related]
3. Surface phenotype of clonogenic cells in acute myeloid leukemia defined by monoclonal antibodies.
Lange B; Ferrero D; Pessano S; Palumbo A; Faust J; Meo P; Rovera G
Blood; 1984 Sep; 64(3):693-700. PubMed ID: 6590096
[TBL] [Abstract][Full Text] [Related]
4. Immunophenotypic analysis of clonogenic cells in acute lymphoblastic leukemia using an in vitro colony assay.
Hudson AM; Makrynikola V; Kabral A; Bradstock KF
Blood; 1989 Nov; 74(6):2112-20. PubMed ID: 2804349
[TBL] [Abstract][Full Text] [Related]
5. Early expression of MCS2 (CD13) in the cytoplasm of blast cells from acute myeloid leukaemia.
Pombo de Oliveira MS; Matutes E; Rani S; Morilla R; Catovsky D
Acta Haematol; 1988; 80(2):61-4. PubMed ID: 2901804
[TBL] [Abstract][Full Text] [Related]
6. The phenotype of L-CFU and its correlation with the immunological characteristics of the blast cell population in AML.
del Cañizo MC; Almeida J; San Miguel JF; Orfao A; Gonzalez M; Lopez Borrasca A
Ann Hematol; 1994 May; 68(5):233-6. PubMed ID: 8018763
[TBL] [Abstract][Full Text] [Related]
7. Antigenic phenotype of the myeloid leukaemic cells defined by monoclonal antibodies.
Robak T; Korycka A
Arch Immunol Ther Exp (Warsz); 1987; 35(1):33-42. PubMed ID: 3477133
[TBL] [Abstract][Full Text] [Related]
8. Antigenic determinants on myeloid leukaemia colony-forming cells resemble those of normal myeloid progenitor cells and differ from those of circulating blast cells.
Robak T; Dowding C; Garewal G; Hibbin JA; Th'ng KH; Goldman JM
Br J Haematol; 1986 Sep; 64(1):133-48. PubMed ID: 2428394
[TBL] [Abstract][Full Text] [Related]
9. Heterogeneity of clonogenic cells in acute myeloblastic leukemia.
Sabbath KD; Ball ED; Larcom P; Davis RB; Griffin JD
J Clin Invest; 1985 Feb; 75(2):746-53. PubMed ID: 3855866
[TBL] [Abstract][Full Text] [Related]
10. Analysis of the individual and combined reactivities of monoclonal antibodies H25, H366, and MY9 with normal progenitor cells and blast cells from patients with acute myeloblastic leukemia.
Wisniewski D; Strife A; Arlin Z; Knowles R; Lambek C; Gulati S; McHendry B; McKenzie S; Clarkson B
Leukemia; 1989 Jun; 3(6):446-52. PubMed ID: 2657231
[TBL] [Abstract][Full Text] [Related]
11. Antibody-producing human-human hybridomas. III. Derivation and characterization of two antibodies with specificity for human myeloid cells.
Andreasen RB; Olsson L
J Immunol; 1986 Aug; 137(3):1083-90. PubMed ID: 3459756
[TBL] [Abstract][Full Text] [Related]
12. CD117 (c-kit) is a restricted antigen of acute myeloid leukemia and characterizes early differentiative levels of M5 FAB subtype.
Cascavilla N; Musto P; D'Arena G; Melillo L; Carella AM; Petrilli MP; Sanpaolo G; Carotenuto M
Haematologica; 1998 May; 83(5):392-7. PubMed ID: 9658721
[TBL] [Abstract][Full Text] [Related]
13. Variable differentiation of human acute myeloid leukaemia during colony formation in vitro: a membrane marker analysis with monoclonal antibodies.
Touw I; Löwenberg B
Br J Haematol; 1985 Jan; 59(1):37-44. PubMed ID: 3882131
[TBL] [Abstract][Full Text] [Related]
14. Most acute myeloid leukemia progenitor cells with long-term proliferative ability in vitro and in vivo have the phenotype CD34(+)/CD71(-)/HLA-DR-.
Blair A; Hogge DE; Sutherland HJ
Blood; 1998 Dec; 92(11):4325-35. PubMed ID: 9834239
[TBL] [Abstract][Full Text] [Related]
15. Immunophenotype distinction between acute promyelocytic leukaemia and CD15- CD34- HLA-DR- acute myeloid leukaemia with nucleophosmin mutations.
Ferrari A; Bussaglia E; Úbeda J; Facchini L; Aventin A; Sierra J; Nomdedéu JF
Hematol Oncol; 2012 Sep; 30(3):109-14. PubMed ID: 21812014
[TBL] [Abstract][Full Text] [Related]
16. [The immunophenotypic and clinical characteristics of NPM1 mutated acute myeloid leukemia patients].
Liu YR; Chang Y; Ruan GR; Qin YZ; Lai YY; Shi HX; Wang YZ; Li LD; Jiang B; Li JL
Zhonghua Xue Ye Xue Za Zhi; 2013 Feb; 34(2):98-103. PubMed ID: 23611213
[TBL] [Abstract][Full Text] [Related]
17. Application of monoclonal antibodies in the antigenic characteristics of normal myeloid progenitor cells and clonogenic blasts in acute myeloid leukaemia.
Robak T
Arch Immunol Ther Exp (Warsz); 1988; 36(1):71-84. PubMed ID: 3233065
[TBL] [Abstract][Full Text] [Related]
18. Prognostic importance of immunophenotyping in adults with acute myelocytic leukaemia: the significance of the stem-cell glycoprotein CD34 (My10).
Geller RB; Zahurak M; Hurwitz CA; Burke PJ; Karp JE; Piantadosi S; Civin CI
Br J Haematol; 1990 Nov; 76(3):340-7. PubMed ID: 1702006
[TBL] [Abstract][Full Text] [Related]
19. [Biological properties and sensitivity to induction therapy of differentiated cells expressing atypical immunophenotype in acute leukemia of children].
Pituch-Noworolska A
Folia Med Cracov; 2001; 42(3):5-80. PubMed ID: 12353422
[TBL] [Abstract][Full Text] [Related]
20. Contrasting antigenic maturation patterns in M0-M2 versus M3 acute myeloid leukemias.
Lewis RE; Cruse JM; Webb RN; Sanders CM; Beason K
Exp Mol Pathol; 2007 Oct; 83(2):269-73. PubMed ID: 17603036
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
